Résumé :
|
[BDSP. Notice produite par INIST WtR0xtjJ. Diffusion soumise à autorisation]. Objectives. This study assessed clinicians'compliance with Centers for Disease Control and Prevention recommendations for follow-up of children with blood lead (BPb) levels of 0.48 mumol/L (10 mug/dL) or higher. Methods. Clinicians'success at follow-up was determined for 3 BPb ranges : >= 0.97 mumol/L, 0.73 through 0.92 mumol/L, and 0.48 through 0.68 mumol/L (>=20 mug/dL, 15-19 mug/dL, and 10-14 mug/dL, respectively). Results. A total of 410 children with elevated BPb levels were followed over a 12-month period ; within 4 months, 71% of those with initial levels of 0.97 mumol/L or greater were retested and 57% and 34% of children with initial BPb levels of 0.73 through 0.92 mumol/L and 0.48 through 0.68 mumol/L, respectively, were retested. Conclusions. Follow-up of children with elevated BPb levels is inadequate within an urban ambulatory care network.
|